|Bid||296.68 x 800|
|Ask||307.63 x 800|
|Day's range||298.88 - 305.70|
|52-week range||172.05 - 413.20|
|Beta (5Y monthly)||1.63|
|PE ratio (TTM)||75.83|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Align Technology (ALGN) have performed compared to their sector so far this year.
Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Align Technologies (ALGN) introduces a series of software innovations to accelerate the digital practice transformation.